Does PEMBROLIZUMAB Cause Epistaxis? 283 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Epistaxis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.3% of all adverse event reports for PEMBROLIZUMAB.
283
Reports of Epistaxis with PEMBROLIZUMAB
0.3%
of all PEMBROLIZUMAB reports
39
Deaths
134
Hospitalizations
How Dangerous Is Epistaxis From PEMBROLIZUMAB?
Of the 283 reports, 39 (13.8%) resulted in death, 134 (47.3%) required hospitalization, and 11 (3.9%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which PEMBROLIZUMAB Alternatives Have Lower Epistaxis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G